Overall rank by patents
#24,799
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 2 technology areas, active 2016–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
The verdict
Medical holds 11 US patents across 2 technology areas, rank #24,799 of 50,000 tracked assignees.
Medical Specialties, Inc. has been granted 11 US utility patents between 2016 and 2024, placing Medical Specialties, Inc. at rank #24,799 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.2 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a US Corporation, Medical Specialties, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Medical sits between Max Delbrück-centrum Für Molekulare Medizin (11 patents, rank #24,795) and Meike Technology (beijing) Ltd. (11 patents, rank #24,803) - the closest US assignees by grant volume. The composite Innovation Score of 30.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 5 in the 2015–2019 window, a +20% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Medical Specialties, Inc.'s 20.2 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Medical Specialties, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Max Delbrück-Centrum Für Molekulare Medizin
11 patents
Maxion Wheels Germany Holding GmbH
11 patents
Maxitrol Company
11 patents
Med-Genesis, LLC
11 patents
Medovex Corp.
11 patents
Medtronic CoreValve LLC
11 patents
Meetup, Inc.
11 patents
Meike Technology (Beijing) Ltd.
11 patents
Medical Specialties, Inc.
11 patents
What this shows Medical holds 11 patents at rank #24,799, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Medical's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
31 Top 65% higher than 35% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 18.2% |
| 2017 | 2 | 18.2% |
| 2019 | 1 | 9.1% |
| 2020 | 2 | 18.2% |
| 2021 | 1 | 9.1% |
| 2023 | 2 | 18.2% |
| 2024 | 1 | 9.1% |
Top 2 of 2 technology areas
Overall rank by patents
#24,799
Across all tracked assignees
30.7 out of 100
How to use this portfolio
Medical's 11 grants land it in the top 65% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.